Authors:
Wenzel, S
Metternich, FU
Sagowski, C
Neuber, K
Kehrl, W
Citation: S. Wenzel et al., Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: Localization of the primary tumor is a prognostic factor., LARY RH OTO, 80(6), 2001, pp. 313-317
Citation: J. Wehner et K. Neuber, Staphylococcus aureus enterotoxins induce histamine and leukotriene release in patients with atopic eczema, BR J DERM, 145(2), 2001, pp. 302-305
Authors:
Weichenthal, M
Godorr, M
Altenhoff, J
Neuber, K
Breitbart, EW
Citation: M. Weichenthal et al., Effects of whole-body UVB irradiation on cytokine production by peripheralblood mononuclear cells from stage I melanoma patients, ARCH DERM R, 292(7), 2000, pp. 348-353
Authors:
Heinzerling, LM
Urbanek, M
Funk, JO
Peker, S
Bleck, O
Neuber, K
Burg, G
von den Driesch, P
Dummer, R
Citation: Lm. Heinzerling et al., Reduction of tumor burden and stabilization of disease by systemic therapywith anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma, CANCER, 89(8), 2000, pp. 1835-1844
Authors:
Neuber, K
Dieck, AT
Blodorn-Schlicht, N
Itschert, G
Karnbach, C
Citation: K. Neuber et al., Treosulfan is an effective alkylating cytostatic for malignant melanoma invitro and in vivo, MELANOMA RE, 9(2), 1999, pp. 125-132
Authors:
Cree, IA
Neale, MH
Myatt, NE
de Takats, PG
Hall, P
Grant, J
Kurbacher, CM
Reinhold, U
Neuber, K
MacKie, RM
Chana, J
Weaver, PC
Khoury, GG
Sartori, C
Andreotti, PE
Citation: Ia. Cree et al., Heterogeneity of chemosensitivity of metastatic cutaneous melanoma, ANTI-CANC D, 10(5), 1999, pp. 437-444
Authors:
Weichenthal, M
Siemann, U
Neuber, K
Breitbart, EW
Citation: M. Weichenthal et al., Expression of complement regulator proteins in primary and metastatic malignant melanoma, J CUT PATH, 26(5), 1999, pp. 217-221
Authors:
Becker, J
Brocker, EB
Dummer, R
Enk, A
Garbe, C
Hauschild, A
Hein, R
Kaufmann, R
Krahn, G
Lohmann, F
Luther, H
Mauch, C
Mohr, P
Nashan, D
Neuber, K
Peter, RU
Reinhold, U
Schadendorf, D
Sebastian, G
Soyer, P
Stadler, R
Stolz, W
Tilgen, W
Trefzer, U
Tronnier, M
Ulrich, J
Volkenandt, M
Citation: J. Becker et al., Current position of the Working Group on Dermatological Oncology on high-dose therapy with interferon alpha 2b, HAUTARZT, 50(6), 1999, pp. 395-397